SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-18-011114
Filing Date
2018-02-21
Accepted
2018-02-21 16:56:18
Documents
3
Effectiveness Date
2018-02-21

Document Format Files

Seq Description Document Type Size
1 8-K a18-6624_18k.htm DEFA14A 48714
2 EX-99.1 a18-6624_1ex99d1.htm EX-99.1 14534
3 GRAPHIC g66241mmi001.jpg GRAPHIC 2493
  Complete submission text file 0001104659-18-011114.txt   67852
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36856 | Film No.: 18629172
SIC: 2834 Pharmaceutical Preparations